SG90096A1 - Process for preparing growth hormone secretagogues - Google Patents

Process for preparing growth hormone secretagogues

Info

Publication number
SG90096A1
SG90096A1 SG200000835A SG200000835A SG90096A1 SG 90096 A1 SG90096 A1 SG 90096A1 SG 200000835 A SG200000835 A SG 200000835A SG 200000835 A SG200000835 A SG 200000835A SG 90096 A1 SG90096 A1 SG 90096A1
Authority
SG
Singapore
Prior art keywords
growth hormone
hormone secretagogues
preparing growth
preparing
secretagogues
Prior art date
Application number
SG200000835A
Other languages
English (en)
Inventor
Frank Robert Busch
Charles Kwok-Fung Chiu
Clifford Nathaniel Meltz
Ronald James Post
Peter Robert Rose
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of SG90096A1 publication Critical patent/SG90096A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
SG200000835A 1999-02-26 2000-02-16 Process for preparing growth hormone secretagogues SG90096A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12274599P 1999-02-26 1999-02-26

Publications (1)

Publication Number Publication Date
SG90096A1 true SG90096A1 (en) 2002-07-23

Family

ID=22404505

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200000835A SG90096A1 (en) 1999-02-26 2000-02-16 Process for preparing growth hormone secretagogues

Country Status (43)

Country Link
US (2) US6541634B2 (enExample)
EP (2) EP1449842A1 (enExample)
JP (3) JP3437813B2 (enExample)
KR (2) KR100372063B1 (enExample)
CN (3) CN1515570A (enExample)
AP (1) AP1221A (enExample)
AR (2) AR029617A1 (enExample)
AT (1) ATE277944T1 (enExample)
AU (1) AU764122B2 (enExample)
BG (1) BG104175A (enExample)
BR (2) BRPI0017522B8 (enExample)
CA (1) CA2299495C (enExample)
CO (1) CO5160252A1 (enExample)
DE (1) DE60014212T2 (enExample)
DK (1) DK1031575T3 (enExample)
DZ (1) DZ3018A1 (enExample)
EA (1) EA003218B1 (enExample)
EE (1) EE200000193A (enExample)
ES (1) ES2226712T3 (enExample)
GT (1) GT200000018A (enExample)
HN (1) HN2000000021A (enExample)
HR (1) HRP20000103A2 (enExample)
HU (1) HUP0000907A3 (enExample)
ID (1) ID24861A (enExample)
IL (2) IL134599A (enExample)
IN (1) IN192352B (enExample)
IS (1) IS5380A (enExample)
MA (1) MA25072A1 (enExample)
NO (1) NO20000965L (enExample)
NZ (1) NZ503062A (enExample)
OA (1) OA11325A (enExample)
PA (1) PA8491201A1 (enExample)
PE (1) PE20001550A1 (enExample)
PL (1) PL338628A1 (enExample)
PT (1) PT1031575E (enExample)
SG (1) SG90096A1 (enExample)
SI (1) SI1031575T1 (enExample)
SK (1) SK284982B6 (enExample)
TN (1) TNSN00035A1 (enExample)
TR (1) TR200000536A2 (enExample)
TW (2) TW200718702A (enExample)
UA (1) UA70306C2 (enExample)
ZA (1) ZA200000888B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1132388A3 (en) * 2000-03-09 2004-03-03 Pfizer Products Inc. Hexahydropyrazolo[4,3-c]pyridine metabolites
EP1289526A4 (en) 2000-05-30 2005-03-16 Merck & Co Inc MELANOCORTIN RECEPTOR AGONISTS
WO2004103983A1 (en) * 2003-05-26 2004-12-02 Biocon Limited Process for the preparation of s(+)-2-ethoxy-4-[n-{1-(2-piperidinophelyl)-3-methyl-1- butyl} aminocarbonylmethyl]benzoic acid derivatives
WO2005027913A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue
US9117477B2 (en) 2013-05-08 2015-08-25 HGST Netherlands B.V. Perpendicular magnetic recording media having novel seed layer
TWI629982B (zh) 2013-05-28 2018-07-21 拉夸里亞創藥股份有限公司 多晶型形式
CN109320515A (zh) * 2018-11-22 2019-02-12 常州大学 一种Capromorelin手性中间体的不对称合成方法
WO2024217441A1 (zh) * 2023-04-21 2024-10-24 长春金赛药业有限责任公司 GHSR 1a激动剂、药物组合物及其制备方法和应用
CN119285632B (zh) * 2024-10-09 2026-08-11 威海中腾医药科技有限公司 一种基于酵母醇脱氢酶催化氧化的卡普瑞林中间体的制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7445698A (en) * 1997-06-25 1999-01-04 Pfizer Products Inc. Treatment of insulin resistance with growth hormone secretagogues

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610980D0 (en) 1986-05-06 1986-06-11 Ici America Inc Heterocyclic fused tricyclic compounds
GB8901423D0 (en) 1989-01-23 1989-03-15 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof
US5578593A (en) 1992-12-11 1996-11-26 Merck & Co., Inc. Spiro piperidines and homologs promote release of growth hormone
BR9408019A (pt) 1993-11-09 1997-08-26 Merck & Co Inc Composto composição util para aumentar a produção endógena ou a liberaçao de hormonio do crescimento em ser humano ou um animal e para o tratamento da osteoporose processos para aumentar os niveis de hormônio do crescimento em um ser humano ou um animal e a eficácia de alimentação promover o crescimento aumentar a produçao de leite e melhorar a qualidade da carcaça de gado para tratar ou previnir uma condição selecionada para tratar osteoporose e para preparar um composto
US5609150A (en) 1995-04-18 1997-03-11 Maged; Jeffrey M. Method for dilating respiratory passages
TW432073B (en) 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
AU2334097A (en) 1996-03-21 1997-10-10 Merck & Co., Inc. 4-spiroindoline piperidines promote release of growth hormone
AU2722297A (en) 1996-04-03 1997-10-22 Merck & Co., Inc. Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
US6251902B1 (en) 1997-06-25 2001-06-26 Pfizer Inc. Dipeptide derivatives as growth hormone secretagogues
UA53716C2 (uk) 1997-06-25 2003-02-17 Пфайзер Продактс Інк. Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти)

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7445698A (en) * 1997-06-25 1999-01-04 Pfizer Products Inc. Treatment of insulin resistance with growth hormone secretagogues

Also Published As

Publication number Publication date
KR20020065455A (ko) 2002-08-13
TR200000536A2 (tr) 2000-09-21
TW200718702A (en) 2007-05-16
DZ3018A1 (fr) 2004-03-20
SK2302000A3 (en) 2000-11-07
EA200000172A2 (ru) 2000-08-28
BRPI0000967B8 (pt) 2021-12-07
AR053722A2 (es) 2007-05-16
BRPI0000967A (pt) 2001-09-11
HUP0000907A2 (en) 2001-03-28
JP2000247974A (ja) 2000-09-12
US20020002283A1 (en) 2002-01-03
DK1031575T3 (da) 2005-01-03
IL134599A (en) 2006-12-10
EE200000193A (et) 2000-10-16
EP1031575B1 (en) 2004-09-29
IL157103A (en) 2007-07-24
JP2003327585A (ja) 2003-11-19
TWI286142B (en) 2007-09-01
CN1515570A (zh) 2004-07-28
IN192352B (enExample) 2004-04-10
AU764122B2 (en) 2003-08-07
ATE277944T1 (de) 2004-10-15
EA200000172A3 (ru) 2000-10-30
PL338628A1 (en) 2000-08-28
GT200000018A (es) 2001-08-16
ID24861A (id) 2000-08-31
KR20010006698A (ko) 2001-01-26
HN2000000021A (es) 2001-02-02
PA8491201A1 (es) 2001-04-30
NO20000965D0 (no) 2000-02-25
CN1137891C (zh) 2004-02-11
JP3437813B2 (ja) 2003-08-18
US6673929B2 (en) 2004-01-06
CN1837205A (zh) 2006-09-27
OA11325A (en) 2003-10-27
JP4051314B2 (ja) 2008-02-20
AR029617A1 (es) 2003-07-10
BRPI0017522B1 (pt) 2013-09-24
JP2003261565A (ja) 2003-09-19
AU1947100A (en) 2000-08-31
UA70306C2 (en) 2004-10-15
BRPI0017522B8 (pt) 2021-05-25
CO5160252A1 (es) 2002-05-30
ES2226712T3 (es) 2005-04-01
IL157103A0 (en) 2004-02-08
US6541634B2 (en) 2003-04-01
EP1031575A1 (en) 2000-08-30
IL134599A0 (en) 2001-04-30
US20030158414A1 (en) 2003-08-21
EA003218B1 (ru) 2003-02-27
BG104175A (bg) 2000-12-29
DE60014212T2 (de) 2005-12-15
BRPI0000967B1 (pt) 2012-06-12
ZA200000888B (en) 2001-08-23
PT1031575E (pt) 2004-11-30
HU0000907D0 (en) 2000-04-28
KR100372063B1 (ko) 2003-02-14
MA25072A1 (fr) 2000-10-01
BRPI0017522A2 (enExample) 2009-12-22
HRP20000103A2 (en) 2001-04-30
HUP0000907A3 (en) 2001-05-28
DE60014212D1 (de) 2004-11-04
PE20001550A1 (es) 2001-01-11
KR100361783B1 (ko) 2002-11-22
CN1270960A (zh) 2000-10-25
EP1449842A1 (en) 2004-08-25
CA2299495C (en) 2010-06-15
IS5380A (is) 2000-08-27
AP2000001754A0 (en) 2000-03-31
NZ503062A (en) 2001-07-27
SK284982B6 (sk) 2006-03-02
HK1030219A1 (en) 2001-04-27
CA2299495A1 (en) 2000-08-26
SI1031575T1 (en) 2005-02-28
AP1221A (en) 2003-11-03
TNSN00035A1 (fr) 2005-11-10
NO20000965L (no) 2000-08-28

Similar Documents

Publication Publication Date Title
HUP0203206A3 (en) Process for preparing 4-trifluoromethylsulphinylpyrazole derivative
IL126264A0 (en) Process for preparing lactic acid
IL154115A0 (en) Process for the preparation of growth hormone secretagogues
IL153067A0 (en) Growth hormone secretagogues
IL147253A0 (en) Growth hormone formulations
IL144350A0 (en) Growth hormone secretagogues
IL144697A0 (en) Microbial process for preparing paravastatin
IL133043A0 (en) Process and intermediates for growth hormone secretagogues
AP2000001754A0 (en) Process for preparing growth hormone secretagogues
EP1243657A4 (en) PROCESS FOR THE PRODUCTION OF GLYCIN
EG23780A (en) Process for preparing eprosartan
IL131309A0 (en) Process for preparing eprosartan
IL145791A0 (en) Process for preparing mkc-442
EP1089978A4 (en) METHOD FOR PRODUCING OXIMIDAZOLES
EG22139A (en) Process for preparing 4- substituted-1H-indole -3- glyoxamides
HUP0000559A3 (en) Process for preparing cyanoaceticacidesters
GB9926266D0 (en) Plant growth apparatus
EG21526A (en) Improved process for preparing pharmaceutically useful norbenzomorphane derivatives
EP1112071A4 (en) SECRETAGOGUES OF GROWTH HORMONES
IL135809A0 (en) Process for preparing 8-cyclopentyl-6-ethyl-3-[substituted]-5,8-dihydro-4h-1,2,3a,7,8-pentaaza-as-indacenes and intermediates useful therein
HUP0101063A3 (en) Process for preparing alkoxytriazolinone derivatives
IL143306A0 (en) Process for preparing trichloroalkane derivatives
EP1119549A4 (en) PROCESS FOR THE PREPARATION OF SUBSTITUTED 4-1H-INDOLE-3-GLYOXAMIDES
GB9916252D0 (en) Growth hormone formulation
IL143239A0 (en) Process for preparing pyridazin-3-on derivatives